insights_auto
Outlook: 66.7% bullish·3.0% bearish
Go to analysischevron_right
INO:NASDAQ
Inovio Pharmaceuticals Inc
US$1.46
arrow_downward
-1.02%(-0.015) 1D
US$1.44
arrow_downward
-1.32% (-0.019)bedtimeAfter hours
Closed: ኖቬም 12, 4:00:01 ከሰዓት ጂ ኤም ቲ-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INO...
Open
US$1.44
High
US$1.53
Low
US$1.33
Mkt. cap
272.54 ሚ
Avg. vol.
19.06 ሚ
Volume
7.88 ሚ
52-wk high
US$2.72
52-wk low
US$0.56
EPS
-US$1.17
Beta
1.71
Shares outstanding
187.31 ሚ
No. of employees
112
Open
US$1.44
High
US$1.53
Low
US$1.33
Mkt. cap
272.54 ሚ
Avg. vol.
19.06 ሚ
Volume
7.88 ሚ
52-wk high
US$2.72
52-wk low
US$0.56
EPS
-US$1.17
Beta
1.71
Shares outstanding
187.31 ሚ
No. of employees
112
News stories
From web sources and news partners
News Corp
·
ከ54 ደቂቃዎች በፊት
Inovio Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors
MarketWatch
·
ከ54 ደቂቃዎች በፊት
Inovio Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors
GuruFocus
·
ከ11 ሰዓቶች በፊት
Inovio Pharmaceuticals Inc (INO) (Q3 2026) Earnings Call Highlig
Yahoo Finance
·
ከ1 ቀን በፊት
Inovio Pharmaceuticals, Inc. Q3 2026 Earnings Call Summary
Profile
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
About Inovio Pharmaceuticals Inc
CEOJacqueline Shea
Employees112
Founded1999
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websiteinovio.com